GenomeX

GenomeX: Precision Medicine Powered by Genomics GenomeX is an AI-powered prototype designed to support personalized treatment decisions in cancer care. Since patients with the same diagnosis can respond differently to the same drug, GenomeX combines genomic information with clinical data to predict how a patient may respond to specific treatments. Users can enter key genetic variants along with details such as age, sex, diagnosis, cancer stage, and previous treatments. The system then generates ranked drug-response predictions, including likely responder, partial responder, or non-responder. It also provides confidence scores and highlights the genetic and clinical factors that most influenced each prediction, making the results easier for clinicians and researchers to understand. The prototype was developed as a modern web application with a responsive interface, a lightweight backend, and a simulated machine-learning prediction layer. Because the project uses synthetic patient profiles, it can be demonstrated without exposing real patient information. A major focus of the design was interpretability, since healthcare professionals need to understand the reasoning behind an AI-generated recommendation rather than receiving an unexplained result. During development, the team worked to balance scientific credibility with the limitations of a prototype. Other challenges included simplifying complex genomic information, presenting probabilities clearly, and creating a trustworthy healthcare interface within a limited development timeframe. The team successfully built an end-to-end system that demonstrates the complete process, from entering patient information to viewing personalized treatment insights. They also created a clear results dashboard and showed how AI could identify relationships between genetic mutations and drug responses in an accessible way. Through the project, the team learned that combining clinical and genomic data can reveal valuable patterns, even in a simplified model. They also recognized that interpretability, user experience, data privacy, and ethical responsibility are just as important as prediction accuracy in healthcare applications. In the future, GenomeX could be expanded by using real-world genomic datasets, training advanced models such as gradient boosting or neural networks, supporting more cancer types and drug classes, and adding tools such as SHAP-based explanations and pathway-level analysis. Collaboration with research institutions and clinical teams could help validate the system and guide its development toward a secure, auditable, and production-ready platform. GenomeX represents an early step toward making precision medicine more accessible by helping move treatment decisions away from a one-size-fits-all approach and toward care tailored to each patient’s unique biological profile.